This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit March 25, 2015

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

HPV-16 infection is associated with improved survival in advanced esophageal cancer
Oncology Nurse Advisor
For patients with advanced-stage esophageal squamous cell carcinoma, human papillomavirus (HPV)-16 infection is associated with improved survival and treatment response, according to a study published online Feb. 24 in the Journal of Digestive Diseases. Wen-Lun Wang, M.D., from the E-Da Hospital/I-Shou University in Taiwan, China, and colleagues examined the impact of HPV infection on the prognosis and treatment response of ESCC in a cohort of 150 patients. The presence and subtype of HPV-DNA in tumor specimens was assessed by polymerase chain reaction and sequencing.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


The American Society for Cytotechnology celebrates Medical Laboratory Professionals Week
ASCT
April 19-25, 2015

Medical Laboratory Professionals Week is an annual celebration of all laboratory personnel who play a critical role in every aspect of health care. Lab Week is the perfect time to honor the more than 300,000 medical laboratory professionals who work behind the scenes performing and interpreting more than 10 billion laboratory tests in the US per year. ASCT is proud to be one of 14 organizations that sponsor this important week in giving thanks to all laboratory professionals for their dedication to quality patient care.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


UPCOMING EVENTS

Date Event Location More information

Available for 6 months after subscribing

Quality Assessment Center (QAC) Cell Blocks Basics Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


Phone intervention beneficial for cervical cancer survivors
Cancer Therapy Advisor
A psychosocial telephone counseling intervention can be beneficial for cervical cancer survivors, according to a study published online in the Journal of Clinical Oncology. Lari Wenzel, Ph.D., from the University of California at Irvine, and colleagues examined the effect of a PTC intervention on quality of life in 204 survivors of cervical cancer who were at least nine and less than 30 months from diagnosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV vaccination rates lower among the wealthy
Medical Xpress
Parents in higher socio-economic areas are less likely to allow their children to be vaccinated against human papillomavirus, new research from Massey University indicates. HPV is a sexually transmitted infection that can lead to cervical and other cancers. A government-funded immunisation programme targets girls in year 8 and requires parental approval.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Building momentum against cervical cancer
MedPage Today
A new study from the CDC shows that two-thirds of cancer survivors remain alive 5 years after diagnosis. Advances in the diagnosis and treatment of cervical cancer have contributed to the improved outlook that cancer patients have today. Since its introduction more than 50 years ago, routine Pap testing to screen for cervical cancer has reduced deaths from the disease by more than 70 percent. Effective prevention and improved screening strategies offer the potential to continue to reduce the number of women affected by cervical cancer in the near future.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV vaccine in teens: No license for sexual activity
Medscape
Despite the fact that 45 percent of women aged 20-24 years have evidence of exposure to human papillomavirus, uptake of the HPV vaccines has significantly lagged behind that of other adolescent vaccinations. The three-dose nature of the vaccine contributes to the difficulty in completing the series, but persistent concerns that vaccination might lead to sexual promiscuity continue to be raised in studies that evaluate barriers to delivery. Although smaller previous studies have demonstrated a lack of association between HPV vaccination and later promiscuity or measures of high-risk sexual behavior, this study used longitudinal data from large, nationally representative insurance samples to address the question.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New HPV vaccine approved after international phase 2/3 trial
Oncology Nurse Advisor
A pivotal international phase 2/3 clinical trial has demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease. The trial data indicate that if populations are vaccinated with Gardasil 9 approximately 90 percent of all cervical cancers worldwide can be prevented. Cervical cancer is diagnosed in approximately 12,000 women each year in the United States and another 4,000 die annually from the disease. However, most cervical cancers are preventable through immunization against the human papillomavirus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of ASCT Viewpoint? Click here to visit the ASCT Viewpoint archive page.


Urging HPV vaccine for boys could protect more people at same price
Medical Xpress
A Duke University study proposes a strategy to better use limited public health care dollars for protecting more people from a sexually transmitted infection called human papillomavirus and the cancers it can cause. Public health programs that devote a portion of their funding to encourage more boys to be vaccinated against HPV — rather than merely attempting to raise coverage among girls — may ultimately protect more people for the same price, the study suggests. The findings appear online in the journal Epidemics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


Novel anticoagulants target cancer patients with CVC
By Dr. Afsaneh Motamed-Khorasani
Anticoagulants have been traditionally used to treat venous thromboembolism, which is a major healthcare problem. Sometimes, there is a need in cancer patients to have a central venous catheter, which could in turn increase the chance of thrombosis. Therefore, the potential for the use of parenteral anticoagulants is being studied in ambulatory cancer patients undergoing chemotherapy, radiation or hormonal therapies that otherwise lack the prophylactic or therapeutic indication for the use of these category of drugs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
March 11, 2015
Feb. 25, 2015
Feb. 11, 2015
Jan. 28, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063